Comparison between Astec Lifesciences Rights Issue 2025 and Infibeam Avenues Rights Issue 2025.
Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Astec Lifesciences Rights Issue 2025 and Infibeam Avenues Rights Issue 2025. Astec Lifesciences Rights Issue 2025 is listed on BSE, NSE while Infibeam Avenues Rights Issue 2025 is listed on BSE, NSE.
| Astec Lifesciences Limited | Infibeam Avenues Ltd | |
|---|---|---|
| Logo |  |  |
| Listing At | BSE, NSE | BSE, NSE |
| Terms of Payment | Issue Price of Rs 890/- per share is payable at the time of Application in the Rights Issue. | Issue Price of Rs.10/- per share is payable as Rs. 5.00 per share on Application. The remaining Rs 5.00 will be called within one or more subsequent calls by the board of the Company at its sole discretion from time to time. |
| Entitlement | 1 Rights Equity Share(s) for every 7 fully paid-up Equity Shares held on Record Date | 67 Rights Equity Share(s) for every 267 fully paid-up Equity Shares held on Record Date |
| Application Form | Application Form  | Application Form |
| Letter of Offer | Letter of Offer | Letter of Offer |
| Registrar | MUFG Intime India Pvt.Ltd. | Alankit Assignments Ltd. |
| Lead Managers |
The issue size of Astec Lifesciences Rights Issue 2025 rights issue is ₹249.35 Crores, whereas Infibeam Avenues Rights Issue 2025 rights issue size is ₹699.99 Crores.
| Astec Lifesciences Limited | Infibeam Avenues Ltd | |
|---|---|---|
| Issue Size | 28,01,673 shares | 69,99,85,723 shares |
| Issue Size (Amount) | ₹249.35 Crores | ₹699.99 Crores |
| Issue Price | ₹890 per share | ₹10 per share |
| Face Value | ₹10 per share | ₹1 per share |
Find all the important dates related to the rights issue. The record date of Astec Lifesciences Rights Issue 2025 is Jul 04, 2025 while record date of Infibeam Avenues Rights Issue 2025 is Jun 26, 2025.
| Astec Lifesciences Limited | Infibeam Avenues Ltd | |
|---|---|---|
| Record Date | Jul 04, 2025 | Jun 26, 2025 |
| Credit of Rights Entitlements | Jul 07, 2025 | Jun 27, 2025 |
| Bid/Offer Opens On | Jul 14, 2025 | Jul 03, 2025 |
| Renunciation of Rights Entitlements | Jul 22, 2025 | Jul 07, 2025 |
| Bid/Offer Closes On | Jul 28, 2025 | Jul 11, 2025 |
| Deemed Date of Allotment | Jul 29, 2025 | Jul 15, 2025 |
| Credit Date | Jul 30, 2025 | Jul 16, 2025 |
| Listing Date | Aug 01, 2025 | Jul 16, 2025 |
Comparison of Astec Lifesciences Rights Issue 2025 and Infibeam Avenues Rights Issue 2025 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.
| Astec Lifesciences Limited | Infibeam Avenues Ltd | |||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial | Astec Lifesciences Limited Financial Information (Restated Consolidated)Astec Lifesciences Limited's revenue decreased by 17% and profit after tax (PAT) dropped by 187% between the financial year ending with March 31, 2025 and March 31, 2024.
| Infibeam Avenues Ltd Financial Information (Restated Consolidated)Infibeam Avenues Ltd's revenue increased by 27% and profit after tax (PAT) rose by 51% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||
